Key result
Implantable cardioverter-defibrillator therapy candidacy for patients with prior myocardial infarction and reduced ejection fraction remains unclear, with several factors influencing the decision.
Answers are grounded in this paper and cite their sources.
This paper discusses the factors influencing the decision to use implantable cardioverter-defibrillator therapy in patients with prior myocardial infarction and reduced ejection fraction.
Patients with a history of myocardial infarction and a reduced ejection fraction are at increased risk for life-threatening ventricular arrhythmias. Which of these patients are the most appropriate candidates for implantable cardioverter–defibrillator (ICD) therapy is unclear. Factors influencing the decision are discussed.
No takes yet. Share an insight, caveat, or question.
Robert J. Myerburg (2008) studied this question. Implantable cardioverter-defibrillator therapy candidacy for patients with prior myocardial infarction and reduced ejection fraction remains unclear, with several factors influencing the decision.
Synapse has enriched 10 related papers. Consider them for comparative context: